Skip to main content

PREDICIENDO GENOTIPOS EXITOSOS DE MYCOBACTERIUM TUBERCULOSIS COMBINANDO GENOMICA DE POBLACIONES, APROXIMACIONES FUNCIONALES Y MODELOS DE INFECCION

PID2019-104477RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Deciphering the tangible spatio-temporal spread of a 25 years tuberculosis outbreak boosted by social determinants

  • López, Mariana G.
  • Campos-Herrero, M. Isolina
  • Torres-Puente, Manuela
  • Cañas, Fernando
  • Comín, Jessica
  • Copado, Rodolfo
  • Wintringer, Penelope
  • Iqbal, Zamin
  • Lagarejos, Eduardo
  • Moreno-Molina, Miguel
  • Pérez-Lago, Laura
  • Pino, Berta
  • Sante, Laura
  • García de Viedma, Darío
  • Samper, Sofía
  • Comas, Iñaki
Background. Outbreak strains are good candidates to look for intrinsic transmissibility as they are responsible for a large number of cases with sustained transmission. However, assessment of the success of long-lived outbreak strains has been flawed by the use of low-resolution typing methods and restricted geographical investigations. We now have the potential to address the nature of outbreak strains by combining large genomic datasets and phylodynamic approaches. Methods. We retrospectively sequenced the whole genome of representative samples assigned to an outbreak circulating in the Canary Islands (GC) since 1993; accounting for ~20% of local TB cases. We selected a panel of specific SNP markers to in-silico search for additional outbreak related sequences within publicly-available TB genomic data. Using this information we inferred the origin, spread and epidemiological parameters of the GC-outbreak. Findings. Our approach allowed us to accurately trace both the historical and recent dispersion of the strain. We evidenced its high success within the Canarian archipelago but found a limited expansion abroad. Estimation of epidemiological parameters from genomic data contradicts a distinct biology of the GC-strain. Interpretation. With the increasing availability of genomic data allowing for an accurate inference of strain spread and key epidemiological parameters, we can now revisit the link between Mycobacterium tuberculosis genotypes and transmission, as routinely done for SARS-CoV-2 variants of concern. We show that the success of the GC-strain is better explained by social determinants rather than intrinsically higher bacterial transmissibility. Our approach can be used to trace and characterize strains of interest worldwide., This study was founded by Instituto de Salud Carlos III (FIS18/0336), Gobierno de Aragon/Fondo Social Europeo Construyendo Europa desde Aragon to SS. European Research Council (101001038-TB-RECONNECT), the Ministerio de Economía, Industria y Competividad (PID2019-104477RB-I00) to IC., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Genomic approaches for tuberculosis management and control, Deploying sequencing advances to the clinic

  • Comas, Iñaki
  • López, Mariana G.
  • Chiner-Oms, Álvaro
  • Farhat, Maha R.
  • Semuto Ngabonziza, Jean Claude
  • Campos, Josefina
  • Moreno-Molina, Miguel
18 páginas, 2 figuras., Research at IC laboratory is funded by European Research Council (TB-RECONNECT Program Grant 101001038), Ministerio de Ciencia (Spanish Government) Project PID2019-104477RB-I00, European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). JSN is funded by research project ‘Innovate to reduce rifampicin resistance tuberculosis in Rwanda and beyond’ with financial support from ITM’s SOFI programme supported by the Flemish Government, Science & Innovation. ACO is supported by a RyC grant RYC2021‐031461‐I funded by MCIN/AEI/ 10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

VIPERA: Viral Intra-Patient Evolution Reporting and Analysis

  • Álvarez-Herrera, Miguel
  • Sevilla, Jordi
  • Ruiz-Rodríguez, Paula
  • Vergara, Andrea
  • Vila, Jordi
  • Cano-Jiménez, Pablo
  • González-Candelas, Fernando
  • Comas, Iñaki
  • Coscollá, Mireia
Viral mutations within patients nurture the adaptive potential of SARS-CoV-2 during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein we describe VIPERA (Viral Intra-Patient Evolution Reporting and Analysis), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. It has been validated using positive and negative control datasets and successfully applied to a novel case, contributing to easy and automatic analysis of intra-patient SARS-CoV-2 sequences., This work was funded by the Spanish Ministry of Science (CNS2022-135116) and the European Commission – NextGenerationEU (Regulation EU 2020/2094), through the Global Health Platform (PTI+ Salud Global) of the Spanish National Research Council (CSIC). MAH and PRR are supported by the PTI+ Salud Global. JS is supported by the CSIC’s JAE intro programme. FGC was funded by project PID2021-127010OB-I00 from the Spanish Ministry of Science and CIPROM2021-053 from the Generalitat Valenciana. IC is funded by the European Research Council (101001038-TB640 RECONNECT) and the Spanish Ministry of Economy, Industry and Competitiveness (PID2019- 104477RB-I00). MC is funded by the Spanish Ministry of Science (PID2021-123443OB-I00)., No